Introduction
============

Non-alcoholic steatohepatitis (NASH) is a subtype of Non-alcoholic fatty liver disease (NAFLD) which has the potential to progress to cirrhosis, hepatic failure or hepatocellular carcinoma ([@B1]-[@B3]). This disease is a liver inflammation caused by fat accumulation in the liver. NASH and NAFLD are common diseases in industrial countries ([@B4]) and have been reported in Australia, India, Japan, the Middle East, New Zealand, North America, South America, northern Europe, southern Europe and South East Asia ([@B4]). In fact nowadays, NASH is the second liver disease in the United States and will be a gold standard for liver transplant in a few years ([@B5]). Biopsy of liver is the only way for diagnosing NASH, but it is a costly and error-prone method ([@B6]) with some risks ([@B7]). So, reducing the cost of early diagnosis of this disease is very important ([@B8]).

Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder that consists primarily of two types: ulcerative colitis and Crohn\'s disease. Both usually involve severe diarrhea, pain, fatigue and weight loss. This disease is caused by dysregulated immune response to host intestinal microﬂora ([@B9]). IBD can be debilitating and sometimes leads to life-threatening complications ([@B10]). IBD patients may develop some complicated diseases such as sclerosing cholangitis and autoimmune hepatitis. Most occurrences of IBD are seen in North America, resulting in high costs of health care measures ([@B11]). IBD patients are more likely to show overweight and obesity ([@B12]-[@B14]). Interestingly, these obese persons are at risk of NASH ([@B15]). Some scientist report the incidence of NASH in IBD in range of 6.2% to 40% ([@B16]-[@B18]). Gisbert et al analyzed 786 IBD patients (49% CD and 51% UC subgroup) and reported 40.8% prevalence of NASH in these patients ([@B16]). In a study by Sourianarayanane et al, the same investigation was performed in 928 patients (53% CD and 47% UC subgroup) to find an incidence of only 8.2%. Indeed, some NASH risk factors were reported in IBD population, such as small bowel surgery ([@B13]), hypertension ([@B13]), obesity ([@B13]), steroid use ([@B13]), active disease ([@B19]), duration of IBD ([@B19]), prior IBD surgery ([@B19]) and anti-TNFα use ([@B19]). However, the pathogenesis of NASH in IBD patients is a mystery because of disease-specific risk factors, such as chronic inflammation, drug-induced hepatotoxicity, steroid exposure, malnutrition and gut dysbiosis that is shared between both diseases ([@B20], [@B21]). Systems biology methods can be helpful to provide a new perspective of shared molecular mechanisms in related diseases such as IBD and NASH ([@B22]-[@B25]). Protein-protein interaction (PPI) network analysis is one of the major fields in systems biology in which analyzed complex interactome of proteins as a main source of data ([@B26]). Using systems biology method such as comparison between gene sets of diseases, constructing PPI network and pathway enrichment can be helpful to decipher the shared mechanism of IBD and NASH. In this study, we reported seven important shared proteins between these diseases that can be used not only as markers of disease, but also as targets for drug designing.

Methods
=======

DisGeNET is a discovery platform containing one of the largest publicly available collections of genes and variants associated with human diseases ([@B27]). The related genes of IBD and NASH were exported from DisGeNET database and used to construct PPI network. The Search Tool for the Retrieval of Interacting Genes/Proteins (STRING), a database for predicted protein-protein interactions at EMBL clusters the extracted results from many protein-protein interactions databases, like Mint, BioGrid, etc. It also uses the information from KEGG pathways and reactome to provide the best annotations for the interactions of one protein ([@B28]). We constructed IBD and NASH networks by submitting gene list to STRING database and analyzed the networks by Cytoscape software ([@B29]).

A network is composed of nodes (e.g., genes or proteins) and edges/links (e.g., co-expression relationships or physical interactions). In network biology terms, degree, and Betweenness are important centrality parameters that are useful for analysis network topology. Edges/links of a node are called the degree of that node. Nodes with high degree are called hubs and nodes that achieve top-ten or top-five percent of betweenness centrality are called bottlenecks (both based on researcher's definition) ([@B30]). So, nodes that are simultaneously hubs and bottlenecks are named hub-bottlenecks ([@B31]). Average degree (A.D) and standard deviation (SD) of degrees were calculated and nodes with degree above two\*SD + A.D were selected as hub proteins in each network. Also, the top five percent of betweenness centrality measures were selected as bottleneck proteins. Shared genes, hubs and bottleneck proteins of these two networks were extracted and used for further analysis. The common network was constructed by importing shared genes in STRING database and clustered by ClusterONE plugin of Cytoscape software ([@B32]) that finds overlapping protein complexes in a protein interaction network loaded into Cytoscape. (overlap threshold = 1, node penalty = 0, haircut threshold = 0) ([@B33]). Pathway enrichment and the relation between pathways were accomplished using ClueGO and CluePedia plugins of Cytoscape software ([@B34], [@B35]).
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###### 

Shared Hub and Bottleneck genes of IBD and NASH networks. Hub-bottleneck genes that are the same as table 1 are marked with asterisks

  Hubs         Degree   Bottlenecks   B.N
  ------------ -------- ------------- ----------
  GMPS         3        SIRT1         0.116186
  PRKAG2       12       TP53\*\*      0.100492
  MLST8        9        HIF1A         0.086405
  MTOR         18                     
  MAP3K7       22                     
  TRAF6        19                     
  PRKAG1       12                     
  PRKAB1       13                     
  PRKAB2       12                     
  ACTB         3                      
  ACTG1        4                      
  PRKAA2       14                     
  SERPINC1     5                      
  F2           7                      
  RPTOR        18                     
  TLR4\*\*     17                     
  IKBKG        18                     
  BIRC3        12                     
  TRAF3        11                     
  TICAM1       11                     
  UBE2N        12                     
  BIRC2        14                     
  MYD88        15                     
  IKBKB        21                     
  SERPIND1     5                      
  FGG          11                     
  PRKAA1       16                     
  TP53\*\*     20                     
  CREBBP       22                     
  MDM4         5                      
  HIF1A        10                     
  CD14         12                     
  TLR2\*\*     18                     
  AGT\*\*      9                      
  TERT         6                      
  STAT3\*\*    17                     
  JAK2\*\*     20                     
  HMGB1        9                      
  SIRT1        9                      
  PPARG        9                      
  VEGFA        8                      
  LEP          11                     
  IL6          3                      
  IGF1         6                      
  IL1B         8                      
  TGFB1        11                     
  IFNG         4                      
  SERPINE1     7                      
  IL4          3                      
  CSF2         4                      
  APOB         7                      
  GH1          3                      
  TEK          11                     
  CYP3A4\*\*   2                      

###### 

Hub and Bottleneck genes of Common network genes. Hub-bottleneck genes are bolded

  Hubs    Degree   Bottlenecks   Betweenness score
  ------- -------- ------------- -------------------
  JAK2    25       JAK2          0.160941
  TLR4    22       TP53          0.10348
  TP53    19       AGT           0.102813
  TLR2    18       CYP3A4        0.083948
  STAT3   16       TLR4          0.083942

###### 

Enriched pathways list, based on seven genes that are shared between table 1 and table 2

  -----------------------------------------------------------------------------------------------------------------------------------------
  GO Term                                                             Ontology Source        Adj-PValue   Associated Genes Found   GO\
                                                                                                                                   Groups
  ------------------------------------------------------------------- ---------------------- ------------ ------------------------ --------
  Association of TriC/CCT with target proteins during biosynthesis    REACTOME               160.0E-6     STAT3, TP53              0

  IL-6 signaling pathway                                              WikiPathways           7.1E-6       AGT, JAK2, STAT3         1

  activation of JAK2 kinase activity                                  GO_BiologicalProcess   100.0E-6     AGT, JAK2                

  regulation of reactive oxygen species biosynthetic process          GO_BiologicalProcess   180.0E-9     AGT, JAK2, STAT3, TLR4   

  type 1 angiotensin receptor binding                                 GO_MolecularFunction   100.0E-6     AGT, JAK2                

  positive regulation of vascular smooth muscle cell proliferation    GO_BiologicalProcess   210.0E-6     AGT, JAK2                

  positive regulation of nitric oxide biosynthetic process            GO_BiologicalProcess   8.3E-6       AGT, JAK2, TLR4          

  regulation of cardiac muscle cell apoptotic process                 GO_BiologicalProcess   210.0E-6     AGT, JAK2                

  Toll-like Receptor Signaling                                        WikiPathways           170.0E-6     TLR2, TLR4               2

  Simplified depiction of MYD88 distinct input-output pathway         WikiPathways           190.0E-6     TLR2, TLR4               

  ApoE and miR-146 in inflammation and atherosclerosis                WikiPathways           62.0E-6      TLR2, TLR4               

  detection of other organism                                         GO_BiologicalProcess   170.0E-6     TLR2, TLR4               

  lipopolysaccharide receptor activity                                GO_MolecularFunction   18.0E-6      TLR2, TLR4               

  detection of molecule of bacterial origin                           GO_BiologicalProcess   110.0E-6     TLR2, TLR4               

  positive regulation of nitric-oxide synthase biosynthetic process   GO_BiologicalProcess   220.0E-9     JAK2, TLR2, TLR4         

  cellular response to lipoteichoic acid                              GO_BiologicalProcess   100.0E-6     TLR2, TLR4               

  IL-5 Signaling Pathway                                              WikiPathways           90.0E-6      JAK2, STAT3              3

  Physiological and Pathological Hypertrophy of the Heart             WikiPathways           240.0E-6     AGT, STAT3               

  IL17 signaling pathway                                              WikiPathways           210.0E-6     JAK2, STAT3              

  IL-6 signaling pathway                                              WikiPathways           7.1E-6       AGT, JAK2, STAT3         

  Leptin Insulin Overlap                                              WikiPathways           170.0E-6     JAK2, STAT3              

  EPO Receptor Signaling                                              WikiPathways           220.0E-6     JAK2, STAT3              

  Serotonin Receptor 2 and STAT3 Signaling                            WikiPathways           11.0E-6      JAK2, STAT3              

  Growth hormone receptor signaling                                   REACTOME               210.0E-6     JAK2, STAT3              

  activation of JAK2 kinase activity                                  GO_BiologicalProcess   100.0E-6     AGT, JAK2                

  regulation of reactive oxygen species biosynthetic process          GO_BiologicalProcess   180.0E-9     AGT, JAK2, STAT3, TLR4   

  type 1 angiotensin receptor binding                                 GO_MolecularFunction   100.0E-6     AGT, JAK2                

  positive regulation of vascular smooth muscle cell proliferation    GO_BiologicalProcess   210.0E-6     AGT, JAK2                

  JAK-STAT cascade involved in growth hormone signaling pathway       GO_BiologicalProcess   160.0E-6     JAK2, STAT3              

  regulation of cardiac muscle cell apoptotic process                 GO_BiologicalProcess   210.0E-6     AGT, JAK2                
  -----------------------------------------------------------------------------------------------------------------------------------------

Results
=======

From DisGeNET, 838 and 331 genes were extracted for IBD and NASH, respectively. Totally, 113 genes were shared between the two lists and were named common genes. The common genes network that was constructed using STRING database, has 99 nodes and 333 edges and two clusters ([figure 1](#F1){ref-type="fig"}). Five genes were selected as hubs: JAK2, TLR2, TP53, TLR4 and STAT3; and five genes were selected as bottleneck including: JAK2, TP53, AGT, CYP3A4 and TLR2 ([Table 1](#T1){ref-type="table"}). Therefore, in this network, we have three hub- bottleneck genes: JAK2, TLR2 and TP53. Also clustering yielded two cluster: cluster one with 73 nodes (p-value: 0.00004) and cluster two with 23 nodes (p-value: 0.0032) ([figure 1](#F1){ref-type="fig"}). In addition, IBD and NASH networks were constructed by STRING database. The IBD network from STRING analysis consists of 653 nodes and 4110 edges, while the NASH network comprises 257 nodes and 965 edges. Analyzing IBD and NASH networks showed that 54 hubs and three bottlenecks were common between these two networks ([Table 2](#T2){ref-type="table"}). All hubs and bottlenecks in the common gene network appeared in the list of common hubs from IBD and NASH networks ([Table2](#T2){ref-type="table"}). So these seven genes were used for pathways enrichment and gene ontology. Gene ontology results showed 24 pathways that can be classified in four clusters ([Table 3](#T3){ref-type="table"} and [figure 2](#F2){ref-type="fig"}). These clusters were named based on the main cluster's pathway: 1. Association of TriC/CCT with target proteins during biosynthesis; 2. IL-6 signaling pathway; 3. Regulation of reactive oxygen species biosynthetic process; and 4. Positive regulation of nitric oxide biosynthetic process. Due to shared mechanism, some pathways appeared in more than one cluster. CluePedia analysis showed that IL-6 signaling pathway group was the central group that connects other groups ([Figure3](#F3){ref-type="fig"}).

![CluePedia map of enriched pathways, main pathways and their relation to genes are shown. Four groups of GO in table 3 are shown in this figure schematically. Group 0: Association of TriC/CCT with target proteins during biosynthesis, dark green; Group 1: IL-6 signaling pathway, dark blue; Group 2: regulation of reactive oxygen species biosynthetic process, light green; positive regulation of vascular smooth muscle cell proliferation, light blue](GHFBB-10-194-g003){#F3}

Discussion
==========

Systems biology methods such as PPI network analysis and pathway enrichment have been used broadly to discover main proteins and pathways underlay complex diseases ([@B36]). Different types of cancers, various kinds of neurodegenerative diseases and disorders and also many cellular condition are analyzed via protein-protein interaction method ([@B37]-[@B42]) The co-existence of NAFLD with IBD is becoming increasingly recognized ([@B43]). In this study, we used the complete genes list of the two diseases (IBD and NASH) that may have shared mechanism based on risk factors and previous studies ([@B44]). According to network analysis of the common network (see [table 1](#T1){ref-type="table"}) and also findings in [table 2](#T2){ref-type="table"}, it is indicated that seven key genes are related to the two diseases. The comparative study of several diseases has shown that there are common informatics biomarker panels in the studied cases ([@B38], [@B39]) . Five of the seven selected genes (JAK2, TLR2, TP53, TLR4 and STAT3) were in one cluster in Common genes network. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling cascade is a central pathway whose regulation is important for a variety of biological processes and whose disruption can cause progressive NASH ([@B45]). Also, Janus kinase (JAK) inhibitors have been developed as a new small molecule therapy for autoimmune disease such as IBD ([@B46]). On the other hand, Interleukin-6 (IL-6) is among the many cytokines that activate JAK/STAT signaling. Knockout of IL-6 gene affects mice with obesity and NASH ([@B47]). Interestingly, the role of IL-6 in IBD immunopathogenesis and its clinical relevance in IBD therapy and diagnostics are well studied ([@B48]). Also, TLR2 and TP53 have important roles in both IBD and NASH. TLRs are key mediators of innate host defense in the intestine, involved in maintaining mucosal as well as commensal homeostasis ([@B49]). Findings in diverse murine models of colitis have revealed the vital role of TLR dysfunction in IBD pathogenesis ([@B50]). Cengiz et al showed that serum TLR4 levels were elevated in NASH patients in comparison with healthy controls. Moreover, in NASH patients, serum level of TLR4 was able to predict liver fibrosis ([@B51]). TP53, encoding p53 protein, triggers apoptosis in NASH ([@B52]) and IBD patients ([@B53]). The finding (see [table 3](#T3){ref-type="table"}) indicates that JAK2 is involved in 20 biological processes among 30 GO terms (about 70% attributions). STAT3 and AGT, the other two genes, are related to about 40% of terms and TP53 the common genes in many cancer diseases is involved only in one term. Involvement of the key genes in the cluster of biological processes is shown in the [figure 3.](#F3){ref-type="fig"} As depicted in this figure, the central role of TLR4, STAT3 and JAK2 is highlighted. It seems that JAK2, STAT3 and AGT are the most important genes that are connected closely to the two compared diseases.

These results showed that application of systems biology methods unravels the secret behind common mechanism of IBD and NASH diseases. The real impact of IBD therapies on co-existing NAFLD also needs to be further assessed. Also, appropriate screening tools and strategies for the management of co-existing diseases in IBD patients are lacking. Clarification of these issues may enhance early intervention and improve patient outcomes.
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